FDA Inspection
Alexza Pharmaceuticals, Inc.Alexza Pharmaceuticals, Inc. – FDA Inspection, Aug 1, 2025
Record Details
This FDA Inspection record concerns Alexza Pharmaceuticals, Inc., with an inspection on August 1, 2025, issued by the San Francisco District Office, covering human drugs.
View Company Profile
ID · 8e1f7e72-88f4-4c2e-940e-2279b9592391
Inspection Facts
- Inspection number
- 1281572
- FDA center
- Human Drugs
Other FDA inspections of Alexza Pharmaceuticals, Inc.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| December 19, 2025 | Not classified | San Francisco District Office | |
| December 22, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 26, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 21, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 13, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Alexza Pharmaceuticals, Inc.
- FDA Inspection 1300206 - 2025-12-19
- FDA Inspection 1227246 - 2023-12-22
- FDA Inspection 1109014 - 2019-09-26
- FDA Inspection 926541 - 2015-05-21
- FDA Inspection 866702 - 2014-02-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.